Cite
An 18-gene signature based on glucose metabolism and DNA methylation improves prognostic prediction for urinary bladder cancer.
MLA
Liu, Zhuonan, et al. “An 18-Gene Signature Based on Glucose Metabolism and DNA Methylation Improves Prognostic Prediction for Urinary Bladder Cancer.” Genomics, vol. 113, no. 1 Pt 2, Jan. 2021, pp. 896–907. EBSCOhost, https://doi.org/10.1016/j.ygeno.2020.10.022.
APA
Liu, Z., Sun, T., Zhang, Z., Bi, J., & Kong, C. (2021). An 18-gene signature based on glucose metabolism and DNA methylation improves prognostic prediction for urinary bladder cancer. Genomics, 113(1 Pt 2), 896–907. https://doi.org/10.1016/j.ygeno.2020.10.022
Chicago
Liu, Zhuonan, Tianshui Sun, Zhe Zhang, Jianbin Bi, and Chuize Kong. 2021. “An 18-Gene Signature Based on Glucose Metabolism and DNA Methylation Improves Prognostic Prediction for Urinary Bladder Cancer.” Genomics 113 (1 Pt 2): 896–907. doi:10.1016/j.ygeno.2020.10.022.